RINTIVA

Serial Number 98490960
731

Registration Progress

Application Filed
Apr 9, 2024
Under Examination
Nov 5, 2024
Approved for Publication
Sep 10, 2024
Published for Opposition
Sep 10, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: May 05, 2026 293 days

Trademark Image

RINTIVA

Basic Information

Serial Number
98490960
Filing Date
April 9, 2024
Published for Opposition
September 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jul 8, 2025
Application
Pending
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
293 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
May 05, 2026
Extension Available
Until November 05, 2025

Application History

32 events
Date Code Type Description Documents
Jul 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 8, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 8, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 8, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 8, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 6, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 6, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 6, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 5, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 5, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 10, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 21, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 8, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 8, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 8, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...
Apr 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for prevention and treatment of cardiovascular disorders; pharmaceutical preparations for prevention and treatment of hypotension; pharmaceutical preparations for regulating blood pressure

Classification

International Classes
005